Dr Reddy’s Chairman Calls for Innovation-Led Pharma Growth Beyond Generics
Advertisement
He noted that India’s current pathway from discovery to commercialization remains fragmented and would benefit from stronger coordination across the healthcare and research ecosystem.
Dr Reddy’s Laboratories Chairman K Satish Reddy has called for a major shift in the Indian pharma industry’s growth strategy, urging companies to focus on large-scale innovation rather than incremental product enhancements.
Through a new white paper titled “Translational Research Ecosystem: Learnings from the World & Building for India,” he has emphasized the importance of creating an environment where scientific discoveries can more effectively reach patients through new therapies and medical advancements.
According to Reddy, one of the key challenges is the disconnect between scientific research and commercial healthcare applications.
Translational research, which focuses on converting laboratory findings into practical treatments, often requires close collaboration among universities, hospitals, government agencies, and industry partners.
He noted that India’s current pathway from discovery to commercialization remains fragmented and would benefit from stronger coordination across the healthcare and research ecosystem.
Reddy has remarked in discussions about long-term innovation trends, stressing the need for India to develop mechanisms that support promising research through critical stages of development and funding.
The push toward innovation also carries important business implications. Developing new medicines typically requires substantial investment in research and development, often over many years.
Unlike generic drug manufacturing, where costs and timelines are relatively predictable, innovative drug development involves significant uncertainty, including clinical trial risks and regulatory requirements.
As a result, pharmaceutical companies may face short-term pressure on profitability while investing in future growth opportunities.
Stay tuned for more such updates on Digital Health News
